The results, though not conclusive, provide the first evidence that targeting a protein known as PCSK9 could reduce cardiovascular risks for millions of patients.
By REUTERS, New York Times
Sun, 08/31/2014 - 3:36pm
The results, though not conclusive, provide the first evidence that targeting a protein known as PCSK9 could reduce cardiovascular risks for millions of patients.